Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Dr Miele Cosmed GroupFRA:9PU +0.80%70 EV-to-EBITDA is 6.44 as of Sep. 13, 2026, which is 34% below its 10-year median of 9.83. GuruFocus rates FRA:9PU with a GF Score™ of 70/100 and a GF Value™ of €0.86. The stock has 2 warning signs investors should review. Among 1,659 Consumer Packaged Goods companies, Dr Miele Cosmed Group ranks better than 70.34% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Dr Miele Cosmed Group's enterprise value is €59.4 Mil.
Dr Miele Cosmed Group's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was €9.2 Mil. Therefore, Dr Miele Cosmed Group's EV-to-EBITDA for today is 6.44.
The historical rank and industry rank for Dr Miele Cosmed Group's EV-to-EBITDA or its related term are showing as below:
FRA:9PU'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -37.05 Med: 9.83 Max: 2222.17
Current: 6.46
During the past 13 years, the highest EV-to-EBITDA of Dr Miele Cosmed Group was 2222.17. The lowest was -37.05. And the median was 9.83.
FRA:9PU's EV-to-EBITDA is ranked better than 70.34% of 1659
companies
in the Consumer Packaged Goods industry
Industry Median: 9.25
vs FRA:9PU: 6.46
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Dr Miele Cosmed Group (FRA:9PU) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Dr Miele Cosmed Group's PE Ratio (TTM) for today is calculated as:
Dr Miele Cosmed Group's share price for today is €0.504.
Dr Miele Cosmed Group's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.047.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
Dr Miele Cosmed Group EV-to-EBITDA Historical Data
* Premium members only.
The historical data trend for Dr Miele Cosmed Group's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Household & Personal Products subindustry, Dr Miele Cosmed Group's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Dr Miele Cosmed Group EV-to-EBITDA vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Dr Miele Cosmed Group's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Dr Miele Cosmed Group's EV-to-EBITDA falls into.
Dr Miele Cosmed Group's current Enterprise Value is €59.4 Mil.
Dr Miele Cosmed Group's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €9.2 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Dr Miele Cosmed Group (FRA:9PU) has a EV-to-EBITDA of 6.44 as of Sep. 13, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Dr Miele Cosmed Group. This is 34% below median its historical median of 9.83. According to the industry distribution chart, Dr Miele Cosmed Group ranks #492 out of 1659 companies in the Consumer Packaged Goods industry, placing it in the top 29.7%.
Is Dr Miele Cosmed Group's EV-to-EBITDA too high?
Dr Miele Cosmed Group's current EV-to-EBITDA of 6.44 is 34% below median its 10-year median of 9.83. The Consumer Packaged Goods industry median EV-to-EBITDA is 9.25. Dr Miele Cosmed Group's value of 6.44 is 30.4% below this industry median. Based on the distribution chart, Dr Miele Cosmed Group ranks #492 out of 1659 companies in the Consumer Packaged Goods industry, which is above the industry midpoint. Overall, Dr Miele Cosmed Group has a GF Score™ of 70/100, reflecting its overall financial health beyond just this single metric.
How does Dr Miele Cosmed Group's EV-to-EBITDA compare to PG and CL?
According to the Consumer Packaged Goods industry distribution chart, Dr Miele Cosmed Group ranks #492 out of 1659 companies for EV-to-EBITDA. This puts Dr Miele Cosmed Group in the upper half of its industry. The industry median EV-to-EBITDA is 9.25. Dr Miele Cosmed Group's value of 6.44 is 30.4% below this benchmark. While the company's 10-year median is 9.83 vs. the industry median of 9.25, Dr Miele Cosmed Group has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Consumer Packaged Goods company?
The median EV-to-EBITDA among Consumer Packaged Goods companies is 9.25, based on 1,659 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Dr Miele Cosmed Group's current EV-to-EBITDA of 6.44 is 30.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Dr Miele Cosmed Group. For the Consumer Packaged Goods industry, the median EV-to-EBITDA is 9.25 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Dr Miele Cosmed Group's current EV-to-EBITDA is 6.44, which is 34% below median its own 10-year median of 9.83. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dr Miele Cosmed Group stock overvalued right now?
Dr Miele Cosmed Group (FRA:9PU) has a current EV-to-EBITDA of 6.44. The stock's GF Value™ is €0.86, compared to a current price of €0.50 — trading 41.4% below its estimated fair value. The current EV-to-EBITDA is 6.44, which is 34% below median its 10-year median of 9.83 and 30.4% below the Consumer Packaged Goods industry median of 9.25. Dr Miele Cosmed Group's overall GF Score™ is 70/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Dr Miele Cosmed Group (FRA:9PU), the current EV-to-EBITDA is 6.44 as of Sep. 13, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Dr Miele Cosmed Group (FRA:9PU) Overvalued in 2026?
Based on GuruFocus' analysis, Dr Miele Cosmed Group stock appears to be undervalued.
The current stock price of €0.50 is trading 41.4% below its estimated GF Value™ of €0.86.
Key valuation signals for FRA:9PU:
EV-to-EBITDA: 6.44 (34% below median its 10-year median of 9.83)
GF Value™: €0.86 vs. price of €0.50 (41.4% below fair value)
Industry Position: 30.4% below the Consumer Packaged Goods median (#492 of 1659)
No single metric tells the full story. See the FRA:9PU stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Dr Miele Cosmed Group SA is engaged in manufacturing cosmetics and household chemicals for national and international retailers, fulfils consumer needs in the sector of personal care, hygiene and cleanliness. The company's brands include Apart, Biophen, Mole, Bobini, Sofin and Izo.
70GF Score
Get the complete analysis for FRA:9PU
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:9PU has been successfully added to your 
